Vol. I · Iss. 04 · The consensus wireWed, Jul 08 · 21:00 EDT● LIVE
← All insiders
Insider record · § CEO,

10% Treace John T. insider buys

Every disclosed SEC Form 4 open-market purchase by 10% Treace John T. (CEO, · TMCI), with the stock's move after each filing. Disclosures are public record; returns are informational, not investment advice.

Disclosed buys
3
Total bought
$729K
Avg Δ7d
+7.0%
Win rate · 7d
67%
Avg Δ30d
+30.4%
Last filing
2026-06-11

Buy history

FiledTickerCompanyValuePrice @Δ1dΔ7dΔ30d
2026-06-11TMCITreace Medical Concepts, Inc.$211K$4.23−4.0%−0.9%
2026-06-01TMCITreace Medical Concepts, Inc.$178K$3.46+0.3%+2.0%+22.3%
2026-05-28TMCITreace Medical Concepts, Inc.$341K$3.08+12.3%+19.8%+38.6%
Get alerts when insiders buy → Sign up free